Also found in: Dictionary, Thesaurus, Wikipedia.
Related to Corgard: Beta blockers


trademark for a preparation of nadolol, a beta-adrenergic blocking agent used as an antianginal and antihypertensive agent.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.


Apo-Nadolol, Corgard, Novo-Nadolol

Pharmacologic class: Beta-adrenergic blocker (nonselective)

Therapeutic class: Antianginal, antihypertensive

Pregnancy risk category C

FDA Box Warning

Catecholamine hypersensitivity may occur after drug withdrawal. Angina exacerbation and in some cases, myocardial infarction have followed abrupt withdrawal. When discontinuing long-term nadolol, reduce dosage gradually over 1 to 2 weeks and monitor patient carefully. If angina worsens markedly or acute coronary insufficiency develops, reinstate drug promptly and take other appropriate measures to manage angina. Caution patient not to interrupt or stop therapy without physician's advice. Because coronary artery disease is common and may be unrecognized, don't discontinue drug abruptly, even in patients treated only for hypertension.


Blocks stimulation of beta1-and beta2-adrenergic receptor sites, decreasing cardiac output and thereby slowing heart rate and reducing blood pressure


Tablets: 20 mg, 40 mg, 80 mg, 120 mg, 160 mg

Indications and dosages

Angina pectoris

Adults: Initially, 40 mg P.O. daily; may increase by 40 to 80 mg q 3 to 7 days p.r.n., up to a maximum of 240 mg/day


Adults: Initially, 40 mg P.O. daily; may increase by 40 to 80 mg q 7 days p.r.n., up to 320 mg/day

Dosage adjustment

• Renal impairment

Off-label uses

• Hyperthyroidism

• Migraine headache

• Parkinson's tremor


• Hypersensitivity to drug or other beta-adrenergic blockers

• Pulmonary edema or cardiogenic shock

• Sinus bradycardia or heart block

• Heart failure (unless secondary to tachyarrhythmia treatable with beta blockers)

• Bronchial asthma (including severe chronic obstructive pulmonary disease)


Use cautiously in:

• renal or hepatic impairment, pulmonary disease, diabetes mellitus, thyrotoxicosis

• history of severe allergic reactions

• elderly patients

• pregnant or breastfeeding patients

• children (safety not established).


• Give with or without food.

• Be aware that drug may be given alone or with diuretic for hypertension.

Adverse reactions

CNS: dizziness, fatigue, paresthesia, behavior changes, sedation

CV: bradycardia, peripheral vascular insufficiency (Raynaud's phenomenon), heart failure

EENT: blurred vision, dry eyes, nasal congestion

GI: nausea, constipation, diarrhea, abdominal discomfort or bloating, indigestion, anorexia

Respiratory: bronchospasm

Skin: rash


Drug-drug. Amphetamines, ephedrine, epinephrine, norepinephrine, phenylephrine, pseudoephedrine: severe vasoconstriction and bradycardia

Antihypertensives, nitrates: additive hypotension

Clonidine: increased hypotension and bradycardia

Digoxin: additive bradycardia

Diltiazem, general anesthestics, phenytoin (I.V.), verapamil: additive myocardial depression

Insulins, oral hypoglycemics: altered glycemic control

Nonsteroidal anti-inflammatory drugs: decreased antihypertensive action

Thyroid hormones: decreased nadolol efficacy

Drug-behaviors. Acute alcohol ingestion: additive hypotension

Cocaine use: severe vasoconstriction, bradycardia

Patient monitoring

• Monitor vital signs and peripheral circulation. Notify prescriber of heart rate below 55 beats/minute.

• Assess for signs and symptoms of heart failure or bronchospasm.

Patient teaching

• Advise patient to take drug with meals and a bedtime snack to minimize GI upset.

• Teach patient how to measure pulse and blood pressure; tell him when to notify prescriber.

• Instruct patient to avoid over-the-counter products containing stimulants, such as some cold and flu remedies and nasal decongestants.

• Tell diabetic patient and family that drug may mask hypoglycemia symptoms. Advise patient to monitor urine or blood glucose regularly.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and behaviors mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved


A trademark for the drug nadolol.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


Nadalol, see there.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.


A brand name for NADOLOL.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
The beta blockers--propranolol (Inderal), metoprolol (Lopressor), nadolol (Corgard), timolol (Blocadren), atenolol (Tenormin), pindolol (Visken), or acebutolol (Sectral)--may cause insomnia, cold hands and feet, tiredness or depression, a slow heartbeat or may bring on symptoms of asthma.
They include the drugs propanolol hydrochloride (Inderal), atenolol (Tenormin), metoprolol (Lopressor), nadolol (Corgard) and timolol maleate (Blocadren).
Study drugs were the maximum tolerated dose of propranolol (Inderal) 20 to 40 mg 3 times daily, nadolol (Corgard) 40 to 80 mg once daily, and placebo 1 capsule once daily.
"The biggest near-term earnings contributors include generic versions of Bristol-Myers Squibb Co.'s Corgard (nadolol), Ciba Consumer Pharmaceuticals' Lopressor (metoprolol tartrate) and Syntex Laboratories Inc.'s Naprosyn (naproxen).
Aldomet, Sytensin, Tenex, Catapres, Ismelin, Hylorel, reserpine, Inderal, Corgard, Tenormin, Blocadren, Lopressor, Visken, Normodyne/Trandate, Sectral, Levatol, Cartrol, Isoptin/Calan/Verelan, Kerlone